by Spencer Aronfeld | Mar 5, 2014 | Defective Drugs, Low Testosterone
Low T drugs are expensive, and they can be unnecessary and even potentially dangerous to take. As a lawyer who sues drug low T drug companies, I find it ironic that most costly prescription drugs, such as AndroGel, also happen have the largest advertising budgets. It...
by Spencer Aronfeld | Feb 18, 2014 | Defective Drugs
Are American men getting soft? According to a 2006 study in The Journal of Clinical Endocrinology and Metabolism, American men are losing testosterone at a rate of 1% a year. The reasons vary from obesity and toxic exposure to simply aging. When there is a perceived...
by Spencer Aronfeld | Aug 30, 2013 | Defective Drugs
Rebecca Doherty, the Federal Court judge who is presiding over the Actos claim litigation, ordered this week that the lawyers representing both victims and the pharmaceutical giant Takeda meet to attempt to resolve any potential evidentiary disputes before filing...
by Spencer Aronfeld | Aug 27, 2013 | Defective Drugs
As a Florida Actos lawsuit lawyer, I have closely followed the country’s first Actos jury trial which recently took place in Los Angeles, California. In that case, the plaintiff claimed that Takeda, the manufacturer of Actos, failed to warn him of the risk of...
by Spencer Aronfeld | Aug 14, 2013 | Defective Drugs
Leer en Espanol Lawsuits against kidney dialysis drug maker Fresenius are going to be much easier now that the Joint Panel on Multidistrict Litigation (JPML) has ordered that all cases be filed in a consolidated proceeding to Judge Douglas P Woodlock, a Reagan...
by Spencer Aronfeld | Jul 29, 2013 | Defective Drugs, Defective Products
As a defective drugs attorney in Miami, I have read about the Actos cases proliferating in the Lafayette District Court in Louisiana. Actos is a prescription medication made by Takeda for use in the treatment of type 2 diabetes and has been linked to bladder cancer....
